Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NUSINERSEN vs OBINUTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NUSINERSEN vs OBINUTUZUMAB: Safety Overview

Metric NUSINERSEN OBINUTUZUMAB
Total FAERS Reports 7,043 14,189
Deaths Reported 747 1,919
Death Rate 10.6% 13.5%
Hospitalizations 2,188 5,419
Average Patient Age 17.1 yrs 63.8 yrs
% Female Patients 50.1% 41.7%
FDA Approval Date Dec 23, 2016 N/A
Manufacturer Biogen Inc. Genentech, Inc.
Route INTRATHECAL INTRAVENOUS
Marketing Status Prescription Prescription